The DOI matches its Crossref record; 415 of the 422 references it cites were found in a registry or an index.
Inflammation in obesity, diabetes, and related disorders
Open accessAbstract
Obesity leads to chronic, systemic inflammation and can lead to insulin resistance (IR), β-cell dysfunction, and ultimately type 2 diabetes (T2D). This chronic inflammatory state contributes to long-term complications of diabetes, including non-alcoholic fatty liver disease (NAFLD), retinopathy, cardiovascular disease, and nephropathy, and may underlie the association of type 2 diabetes with other conditions such as Alzheimer's disease, polycystic ovarian syndrome, gout, and rheumatoid arthritis. Here, we review the current understanding of the mechanisms underlying inflammation in obesity, T2D, and related disorders. We discuss how chronic tissue inflammation results in IR, impaired insulin secretion, glucose intolerance, and T2D and review the effect of inflammation on diabetic complications and on the relationship between T2D and other pathologies. In this context, we discuss current therapeutic options for the treatment of metabolic disease, advances in the clinic and the potential of immune-modulatory approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Obesity further amplifies systemic inflammation, creating a self-perpetuating cycle that markedly increases the risk of cardiovascular disease and diabetes [38].”
From Navigating the potential of algal peptides: health effects, market applications, and scientific challenges (2026) · cites this paper as [38]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, inflammatory cytokines such as IL-1β and tumor necrosis factor alpha (TNF-α), abundant in the AD brain, suppress GLUT expression, while oxidative stress further destabilizes and inactivates transporter proteins.”
From Toward a Unified Framework in Molecular Neurobiology of Alzheimer’s Disease: Revisiting the Pathophysiological Hypotheses (2026) · cites this paper as [73]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Inflammation, as a basic pathological process, is critically implicated in the pathogenesis and progression of numerous diseases.”
From Picroside II as a Potential Anti-Inflammatory Agent (2026) · cites this paper as [5]
In the citing paper
“Our data using Cd68-eGFP mice support previous findings that obesity is associated with chronic inflammation37, as we observed increased expression numbers of Cd68-eGFP+ cells throughout the mouse.”
From A deep-learning framework reveals whole-body perturbations at cell level (2026) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Research works printed but not linked: 4
- Ebstein, 1876, Zur Therapie des Diabetes Mellitus, insbesondere über die Anwendung des Salicylsauren Natron bei demselben, Berliner Klinische Wochenschrift., 24, 337
- Jonsson, 2013, TREM2 and neurodegenerative disease, N. Engl. J. Med., 369, 1568
- Klover, 2003, Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice, Diabetes, 52, 2784, 10.2337/diabetes.52.11.2784 · DOI · Paper page
- Rohm, 2017, Increased Inflammatory Intestinal Macrophage Subpopulations after High-Fat Diet, Diabetes, 66, 51
Cited by
Sorted by citations
Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments
Ruze, R., Liu, T., Zou, X., Song, J., Chen, Y., Xu, R., Yin, X., & Xu, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1161521 · Cited by 799
Metformin: update on mechanisms of action and repurposing potential
Foretz, M., Guigas, B., & Viollet, B. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00833-4 · Cited by 791
Pathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 603
Signaling pathways and targeted therapies for psoriasis
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 489
Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier
Tryphena, K. P., Shukla, R., Khatri, D. K., & Vora, L. K. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102481 · Cited by 438
Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress
Dludla, P. V., Mabhida, S. E., Ziqubu, K., Nkambule, B. B., Mazibuko-Mbeje, S. E., Hanser, S., Basson, A. K., Pheiffer, C., & Kengne, A. P. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i3.130 · Cited by 409
Overview of oxidative stress and inflammation in diabetes
Sibony, R. W., Segev, O., Dor, S., & Raz, I. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70014 · Cited by 344
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus
Xourafa, G., Korbmacher, M., & Roden, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00898-1 · Cited by 274
The Pharmacological Efficacy of Baicalin in Inflammatory Diseases
Wen, Y., Wang, Y., Zhao, C., Zhao, B., & Wang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119317 · Cited by 238
Excess body weight: Novel insights into its roles in obesity comorbidities
Zhang, X., Ha, S., Lau, H. C.-H., & Yu, J. Q. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.03.008 · Cited by 255
Zhang, Z., Huang, Q., Zhao, D., Lian, F., Li, X., & Qi, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1112363 · Cited by 236
Inflammation and resolution in obesity
Soták, M., Clark, M., Suur, B. E., & Börgeson, E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01047-y · Cited by 260
Adipokines: masterminds of metabolic inflammation
Tilg, H., Ianiro, G., Gasbarrini, A., & Adolph, T. E. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01103-8 · Cited by 234
Insulin resistance in type 2 diabetes mellitus
Accili, D., Deng, Z., & Liu, Q. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01114-y · Cited by 219
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171
Singh, A. P., Shadangi, S., Gupta, P. K., & Rana, S. (2025) · Comprehensive physiology · doi:10.1002/cph4.70003 · Cited by 201
Iron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161
Epithelial–mesenchymal transition in tissue repair and degeneration
Youssef, K. K., & Nieto, M. A. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00733-z · Cited by 165
Microplastics and human health: unveiling the gut microbiome disruption and chronic disease risks
Bora, S. S., Gogoi, R., Sharma, M. R., Anshu, A., Borah, M. P., Deka, P. C., Bora, J., Naorem, R. S., Das, J., & Teli, A. B. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1492759 · Cited by 199
Autoimmune diseases and atherosclerotic cardiovascular disease
Porsch, F., & Binder, C. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01045-7 · Cited by 155
Huo, R., Zhai, L., Liao, Q., & You, X. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01983-5 · Cited by 145
Xue, C., Chen, K., Gao, Z., Bao, T., Dong, L., Zhao, L., Tong, X., & Li, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-022-01016-w · Cited by 146
Bai, X., Guo, Y.-R., Zhao, Z., Li, X., Dai, D.-Q., Zhang, J., Li, Y.-S., & Zhang, C. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217772 · Cited by 140
Li, B., Xin, Z., Gao, S., Li, Y., Guo, S., Fu, Y., Zhang, P., Wang, D., Cheng, J., Liu, L., et al. (2022) · Theranostics · doi:10.7150/thno.78878 · Cited by 115
Shao, Y., Hu, H., Li, Q., Cao, C., Liu, D., & Han, Y. Y. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02165-7 · Cited by 112
Neutrophils Actively Contribute to Obesity-Associated Inflammation and Pathological Complications
Uribe‐Querol, E., & Rosales, C. (2022) · Cells · doi:10.3390/cells11121883 · Cited by 122
Wu, Y., Yang, Y., Zhang, J., Liu, S., & Zhuang, W. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01870-z · Cited by 108
Known and potential health benefits and mechanisms of blueberry anthocyanins: A review
Wu, Y., Han, T., Yang, H., Lyu, L., Li, W., & Li, W. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103050 · Cited by 113
Chen, W., & Xu, D. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104201 · Cited by 104
Liu, K., Tang, S., Liu, C., Ma, J., Cao, X., Yang, X., Zhu, Y., Chen, K., Liu, Y., Zhang, C., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1337241 · Cited by 104
Siddeeque, N., Hussein, M. H., Abdelmaksoud, A., Newton‐Bishop, J., Attia, A. S., Elshazli, R. M., Fawzy, M. S., & Toraih, E. A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113537 · Cited by 115
Nonresolving inflammation redux
Nathan, C. (2022) · Immunity · doi:10.1016/j.immuni.2022.03.016 · Cited by 103
Sarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Lisco, G., Disoteo, O., Tullio, A. D., Geronimo, V. D., Giagulli, V. A., Monzani, F., Jirillo, E., Cozzi, R. C., Guastamacchia, E., Pergola, G. D., et al. (2023) · Nutrients · doi:10.3390/nu16010063 · Cited by 111
Exosome-Mediated Impact on Systemic Metabolism
Rocha, K. C. E., Ying, W., & Olefsky, J. M. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024535 · Cited by 103
Self-citationKostenko, V. О., Akimov, O. Y., Gutnik, O. M., Kostenko, H., Kostenko, V., Romantseva, T. O., Morhun, Y., Nazarenko, S. M., & Taran, O. V. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15551 · Cited by 97
Inflammation and aging-related disease: A transdisciplinary inflammaging framework
Andonian, B. J., Hippensteel, J. A., Abuabara, K., Boyle, E. M., Colbert, J. F., Devinney, M. J., Faye, A. S., Kochar, B. D., Lee, J., Litke, R. R., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01364-0 · Cited by 109
Vitamin D in Diabetes: Uncovering the Sunshine Hormone’s Role in Glucose Metabolism and Beyond
Wu, J., Atkins, A. R., Downes, M., & Wei, Z. (2023) · Nutrients · doi:10.3390/nu15081997 · Cited by 106
Chen, Y., Guan, M., Wang, R. L., & Wang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1298345 · Cited by 89
Obesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction
Choi, W., Woo, G. H., Kwon, T., & Jeon, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199715 · Cited by 120
Yang, J., Li, S., Li, Z., Yao, L., Liu, M., Tong, K., Xu, Q., Yu, B., Peng, R., Gui, T., et al. (2023) · Advanced Science · doi:10.1002/advs.202304617 · Cited by 89
Zhou, C., She, X., Gu, C., Hu, Y., Ma, M., Qiu, Q., Sun, T., Xu, X., Chen, H., & Zheng, Z. J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci160517 · Cited by 85
Romeo, S., Vidal‐Puig, A., Husain, M., Ahima, R. S., Arca, M., Bhatt, D. L., Diehl, A. M., Fontana, L., Foo, R., Frühbeck, G., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf314 · Cited by 93
Coumarin: A natural solution for alleviating inflammatory disorders
Saadati, F., Chahardehi, A. M., Jamshidi, N., Jamshidi, N., & Ghasemi, D. (2024) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2024.100202 · Cited by 92
The interface of depression and diabetes: treatment considerations
Fanelli, G., Raschi, E., Hafez, G., Matura, S., Schiweck, C., Poluzzi, E., & Lunghi, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03234-5 · Cited by 112
Tkaczenko, H., & Kurhaluk, N. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031098 · Cited by 80
Beneficial Effects of Anti-Inflammatory Diet in Modulating Gut Microbiota and Controlling Obesity
Bagheri, S., Zolghadri, S., & Stanek, A. (2022) · Nutrients · doi:10.3390/nu14193985 · Cited by 98
Respiratory complications of obesity: from early changes to respiratory failure
Shah, N. M., & Kaltsakas, G. (2023) · Breathe · doi:10.1183/20734735.0263-2022 · Cited by 98
Hong, X., Zhou, Y. M., Zhu, Z., Li, Y., Zuo, L., Zhang, Y., Hu, X., Zhu, F., Wang, Y., Fang, M., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.107759 · Cited by 85
Exosomal miRNA-26b-5p from PRP suppresses NETs by targeting MMP-8 to promote diabetic wound healing
Rui, S., Dai, L., Zhang, X., He, M. Y., Xu, F., Wu, W., Armstrong, D. G., You, Y., Xiao, X., Ma, Y., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.050 · Cited by 79
Cytokines as key players in obesity low grade inflammation and related complications
Uti, D. E., Atangwho, I. J., Omang, W. A., Alum, E. U., Obeten, U. N., Udeozor, P. A., Agada, S. A., Bawa, I., & Ogbu, C. O. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100585 · Cited by 116
Ouyang, Y., Quan, Y., Guo, C., Xie, S., Liu, C., Huang, X., Huang, X., Chen, Y., Xiao, X., Ma, N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.922903 · Cited by 74
Modification of lipoprotein metabolism and function driving atherogenesis in diabetes
Luciani, L., Pedrelli, M., & Parini, P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117545 · Cited by 72
An, H., Jang, Y., Choi, J.-I., Hur, J., Kim, S., & Kwon, Y. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.188 · Cited by 75
Lu, L., Chen, Y., Liu, B., Li, X., Wang, J., Nie, Z., & Fu, X. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02754-0 · Cited by 72
Macrophages and T cells in metabolic disorder-associated cancers
Taranto, D., Kloosterman, D. J., & Akkari, L. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00743-1 · Cited by 81
Xiao, D., Lu, L., Liang, B., Xiong, Z., Xu, X., & Chen, W. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115795 · Cited by 69
Takić, M. M., Ranković, S., Girek, Z., Pavlović, S., Jovanović, P., Jovanović, V. B., & Šarac, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094909 · Cited by 75
Obesity: A Global Health Challenge Demanding Urgent Action
Abad‐Jiménez, Z., & Vezza, T. (2025) · Biomedicines · doi:10.3390/biomedicines13020502 · Cited by 67
Yang, J., Liu, S., Li, Y., Fan, Z., Meng, Y., Zhou, B., Zhang, G., & Zhan, H. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216403 · Cited by 66
Xia, W., Liu, Y., Jiang, X., Li, M., Zheng, S., Zhang, Z., Huang, X., Luo, S., Khoong, Y., Hou, M., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01869-4 · Cited by 67
Liu, J., Pan, S., Wang, X., Liu, Z., & Zhang, Y. (2023) · European journal of medical research · doi:10.1186/s40001-023-01431-w · Cited by 74
Seaweed Derived Lipids Are a Potential Anti-Inflammatory Agent: A Review
Jaworowska, A., & Murtaza, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010730 · Cited by 67
Dezfouli, R. A., Khonsari, N. M., Hosseinpour, A., Asadi, S., Ejtahed, H., & Qorbani, M. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01388-0 · Cited by 62
Teng, H., He, Z., Hong, C.-Z., Xie, S.-Z., & Zha, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117809 · Cited by 62
Heavy arch: from inflammatory bowel diseases to metabolic disorders
Adolph, T. E., Meyer, M., Jukic, A., & Tilg, H. (2024) · Gut · doi:10.1136/gutjnl-2024-331914 · Cited by 72
Wu, X., Fan, Y., Chung, K. P. S., Leung, C. O. N., Leung, R. W. H., So, K. K. H., Lei, M. M. L., Chau, W. K., Tong, M., Yu, J. Q., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101900 · Cited by 66
Obesity, diabetes, and inflammation: Pathophysiology and clinical implications
Donath, M. Y., & Drucker, D. J. (2025) · Immunity · doi:10.1016/j.immuni.2025.09.011 · Cited by 66
Self-citationWang, D., Liu, J. Y., Zhong, L., Li, S., Zhou, L., Zhang, Q., Li, M., & Xiao, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1045235 · Cited by 65
Plant polysaccharides: sources, structures, and antidiabetic effects
Wang, H., Li, H., Hou, Y., Zhang, P., & Tan, M. (2023) · Current Opinion in Food Science · doi:10.1016/j.cofs.2023.101013 · Cited by 60
Ullah, A., Din, A. U., Ding, W., Shi, Z., Pervaz, S., & Shen, B. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09800-w · Cited by 60
Lee, S. A., & Riella, L. V. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.02.1435 · Cited by 65
Impact of Maternal Environment and Inflammation on Fetal Neurodevelopment
Lubrano, C., Parisi, F., & Cetin, I. (2024) · Antioxidants · doi:10.3390/antiox13040453 · Cited by 66
Yuan, M., Sun, T., Zhang, Y., Guo, C., Wang, F., Yao, Z., & Yu, L. (2024) · Nutrients · doi:10.3390/nu16121870 · Cited by 63
Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases
Wu, D., Wang, H., Xie, L., & Hu, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.908868 · Cited by 62
Anti-inflammatory role of fenofibrate in treating diseases
Jin, L., Hu, H., Ji, Y., Jia, Z., Peng, M., & Huang, S. (2023) · Biomolecules and Biomedicine · doi:10.17305/bb.2022.8534 · Cited by 58
Physiological role of cytokines in the regulation of mammalian metabolism
Baat, A. D., Trinh, B., Ellingsgaard, H., & Donath, M. Y. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.06.002 · Cited by 62
Self-citationMetaflammation in glucolipid metabolic disorders: Pathogenesis and treatment
Xiong, P., Zhang, F., Liu, F., Zhao, J., Huang, X., Luo, D., & Guo, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114545 · Cited by 59
Lipoxin Mimetics and the Resolution of Inflammation
Godson, C., Guiry, P. J., & Brennan, E. P. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051921-085407 · Cited by 59
Lin, P., Qian, Z., Liu, S., Ye, X., Xue, P., Shao, Y., Zhao, J., Guan, Y., Liu, Z., Chen, Y., et al. (2024) · Advanced Materials · doi:10.1002/adma.202410962 · Cited by 58
Mafe, A. N., Edo, G. I., Akpoghelie, P. O., Gaaz, T. S., Yousif, E., Zainulabdeen, K., Isoje, E. F., Igbuku, U. A., Opiti, R. A., Garba, Y., et al. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10452-2 · Cited by 64
Autolysosomal Dysfunction in Obesity-induced Metabolic Inflammation and Related Disorders
Cheong, L. Y. T., Saipuljumri, E. N., Loi, G. W. Z., Zeng, J., & Lo, C. H. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00638-8 · Cited by 59
Yang, Y., & Liu, A. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02945-9 · Cited by 60
Zheng, J., An, Y., Du, Y., Song, Y., Zhao, Q., & Lu, Y. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.107041 · Cited by 59
Deng, C., Lu, C., Wang, K., Chang, M., Shen, Y., Yang, X., Sun, H., Yao, X., Qiu, C., & Xu, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1344276 · Cited by 61
Innate immune memory in cardiometabolic disease
Bahrar, H., Bekkering, S., Stienstra, R., Netea, M. G., & Riksen, N. P. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad030 · Cited by 53
Wang, Z., He, H., Xie, Y., Li, J., Luo, F., Sun, Z., Zheng, S., Yang, F., Li, X.-X., Chen, X., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02158-6 · Cited by 54
Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus
Zhang, R., Xie, Q., Lu, X., Fan, R., & Tong, N. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01325-9 · Cited by 63
Obesity-induced neuroinflammation and cognitive impairment in young adult versus middle-aged mice
Henn, R. E., Elzinga, S. E., Glass, E., Parent, R., Guo, K., Allouch, A. M., Mendelson, F. E., Hayes, J., Webber‐Davis, I. F., Murphy, G. G., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00323-7 · Cited by 54
Inverse Association between Oxidative Balance Score and Incident Type 2 Diabetes Mellitus
Kwon, Y., Park, H.-M., & Lee, J. (2023) · Nutrients · doi:10.3390/nu15112497 · Cited by 52
Pterostilbene in the treatment of inflammatory and oncological diseases
Liu, P., Tang, W., Xiang, K., & Li, G. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1323377 · Cited by 53
Metabolic Messengers: small extracellular vesicles
Rohm, T. V., Rocha, K. C. E., & Olefsky, J. M. (2025) · Nature Metabolism · doi:10.1038/s42255-024-01214-5 · Cited by 56
Self-citationNutraceutical Properties of Syringic Acid in Civilization Diseases—Review
Bartel, I., Mandryk, I., Horbańczuk, J. O., Wierzbicka, A., & Koszarska, M. (2023) · Nutrients · doi:10.3390/nu16010010 · Cited by 52
Ortega, M. A., Fraile‐Μartinez, O., Montero, C. G., Haro, S., Álvarez-Mon, M. Á., León-Oliva, D. D., Gomez-Lahoz, A. M., Monserrat, J., Atienza-Pérez, M., Díaz, D., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00461-z · Cited by 54
Diabetes Mellitus, Energy Metabolism, and COVID-19
Conte, C., Cipponeri, E., & Roden, M. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad032 · Cited by 51
O‐GlcNAcylation: cellular physiology and therapeutic target for human diseases
Ye, L., Ding, W., Xiao, D., Jia, Y., Zhao, Z., Ao, X., & Wang, J. (2023) · MedComm · doi:10.1002/mco2.456 · Cited by 51
Girard, D., & Vandiedonck, C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.991716 · Cited by 55
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arabshomali, A., Bazzazzadehgan, S., Mahdi, F., & Shariat‐Madar, Z. (2023) · Molecules · doi:10.3390/molecules28207209 · Cited by 56
The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus
Zeng, J., Chen, M., Qiu, F., Wan, H., Wang, J., Yang, F., & Cao, H. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s378284 · Cited by 49
Mulas, A., Cienfuegos, S., Ezpeleta, M., Lin, S., Pavlou, V., & Varady, K. A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1146924 · Cited by 57
The cGAS-STING pathway: a therapeutic target in diabetes and its complications
He, W., Mu, X., Wu, X., Liu, Y., Deng, J., Liu, Y., Han, F. Y., & Nie, X. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad050 · Cited by 50
Metadata
- Authors
- Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y.
- Affiliations
- University of California San Diego (US)
- University of Basel (CH)
- Corresponding author
- Donath, Marc Y.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2022-01
- Volume
- 55
- Issue
- 1
- Pages
- 31-55
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC8773457
- OpenAlex
- W4206799195
- Cited by
- 2,066
- References
- 422
- Citations by year
- 2026: 450 · 2025: 649 · 2024: 512 · 2023: 345 · 2022: 108
- FWCI
- 64.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30 DK063491, DK101395)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2BSP3_200177)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- obesity, type 2 diabetes, chronic inflammation, insulin resistance, beta-cell dysfunction, insulin secretion, impaired glucose tolerance, non-alcoholic fatty liver disease, diabetes complications, Alzheimer's disease, polycystic ovary syndrome, gout, rheumatoid arthritis, cardiovascular disease, kidney disease, retinopathy, immunomodulatory therapy, metabolic disease treatment
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin Resistance, Obesity, Diabetes Complications, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
